Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Pain and Sleep Quality of Infants With Congenital Pulmonary Cystic Disease After Thoracoscopic Surgery

NCT ID: NCT06498583

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-05

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study intends to evaluate the effect of erector spinae plane block on postoperative analgesia and sleep quality in infants with congenital cystic pulmonary disease after thoracoscopic surgery, and provides reference for perioperative pain treatment in children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Severe pain may occur after pediatric thoracic surgery, such as skin incision, rib traction, drainage tube placement, or intercostal nerve dysfunction caused by suture. Pain may cause weakened coughing power to clear secretions, decreased functional residual capacity, leading to pulmonary complications such as atelectasis and pneumonia, and postoperative acute pain develops into chronic pain. It has been reported that postoperative sleep disorders are associated with increased pain scores, which are very unfavorable for postoperative rehabilitation of pediatric patients. In clinical practice, because infants cannot accurately describe pain, their postoperative pain management may not be sufficient and has not received enough attention. But, some studies have shown that infants may feel more severe pain than adults, and the pain has a more obvious and lasting effect on infants and young children than on adults.

Congenital pulmonary cystic disease is a rare congenital pulmonary developmental abnormality in clinic. It can't heal itself and is easy to cause various complications. Once diagnosed, surgical treatment should be considered immediately.

In the past experience, thoracic epidural block and thoracic paravertebral nerve block are commonly used for postoperative analgesia in thoracic surgery, but they have taboos such as abnormal coagulation function, high technical requirements and potential risks of serious complications.

Since the erector spinae plane block (ESPB) was first reported and successfully implemented in 2016, because it is far away from the neural axis, major vascular structures, pleura and other structures, with a lower possibility of complications, simpler operation and higher safety, it has been widely used in perioperative analgesia and acute and chronic pain in cardiothoracic surgery, breast surgery, abdominal surgery, spinal surgery, etc. However, the reports on pediatric patients are still mainly case reports, and there is a lack of large-sample randomized controlled clinical trials. Therefore, this study intends to perform erector spinae plane block under ultrasound guidance to observe the effect on postoperative analgesia and sleep quality in pediatric thoracoscopic surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cystic Adenomatoid Malformation of Lung, Congenital Bronchopulmonary Sequestration Bronchogenic Cyst

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

E group

Group Type EXPERIMENTAL

Ropivacaine

Intervention Type DRUG

0.25 % ropivacaine ( 0.5ml / kg )

erector spinae plane block

Intervention Type PROCEDURE

After the operation, unilateral erector spinae plane block was performed at the T5 level under ultrasound guidance.

P group

Group Type EXPERIMENTAL

Ropivacaine

Intervention Type DRUG

0.25 % ropivacaine ( 0.5ml / kg )

Incision infiltration of local anesthesia

Intervention Type PROCEDURE

After the operation, Incision infiltration of local anesthesia is performed around the surgical incisions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ropivacaine

0.25 % ropivacaine ( 0.5ml / kg )

Intervention Type DRUG

erector spinae plane block

After the operation, unilateral erector spinae plane block was performed at the T5 level under ultrasound guidance.

Intervention Type PROCEDURE

Incision infiltration of local anesthesia

After the operation, Incision infiltration of local anesthesia is performed around the surgical incisions.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* American Society of Anesthesiologists (ASA) status I-II
* age 1 month - 12 mouths old
* preoperative diagnosis was congenital cystic lung disease
* thoracoscopic lung lesion resection(lung lobectomy or segmentectomy)

Exclusion Criteria

* patient with a history of allergy to amide local anesthetics
* family members refused to participate in the study.
* combined congenital heart disease
* patient with skin damage or infection at the proposed puncture site
* patients with scoliosis
Minimum Eligible Age

1 Month

Maximum Eligible Age

12 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lei Xiaoming

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lei Xiaoming

chief physician

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xiaoming Lei, chief physician

Role: STUDY_CHAIR

Second Affiliated Hospital of Xi 'an Jiaotong University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Second Affiliated Hospital of Xi 'an Jiaotong University

Xi’an, Shanxi, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Xiaoming Lei, chief physician

Role: CONTACT

+8613571903125

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xiaoming Lei, chief physician

Role: primary

0086-13571903125

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-015

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.